NCT01425710

Brief Summary

Non-invasive measurements of cardiac output (CO), systemic vascular resistance (SVR), corrected aortic flow time (FTc) and stroke volume (SV) are useful parameters during laparoscopic resection of pheochromocytoma (adrenalectomy) to document the intraoperative changes in volume status and to estimate the volume depletion.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
15

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Aug 2011

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2011

Completed
23 days until next milestone

First Submitted

Initial submission to the registry

August 24, 2011

Completed
6 days until next milestone

First Posted

Study publicly available on registry

August 30, 2011

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2013

Completed
Last Updated

February 13, 2014

Status Verified

February 1, 2014

Enrollment Period

1.9 years

First QC Date

August 24, 2011

Last Update Submit

February 12, 2014

Conditions

Keywords

PheochromocytomaAdrenalectomyCardiac outputFluid managmentEsopagheal doppler sonography

Outcome Measures

Primary Outcomes (7)

  • Cardiac output (CO)

    measured using esophageal doppler

    parameter will be measured continously for the duration of adrenalectomy, an expected average of 3 hours

  • Systemic vascular resistance (SVR)

    measured using esophageal doppler

    parameter will be measured continously for the duration of adrenalectomy, an expected average of 3 hours

  • Stroke volume (SV)

    measured using esophageal doppler

    parameter will be measured continously for the duration of adrenalectomy, an expected average of 3 hours

  • Corrected aortic flow time(FTc)

    measured using esophageal doppler

    parameter will be measured continously for the duration of adrenalectomy, an expected average of 3 hours

  • Central venous pressure

    Measured using esophageal doppler

    parameter will be measured continously for the duration of adrenalectomy, an expected average of 3 hours

  • Heart rate

    parameter will be measured continously for the duration of adrenalectomy, an expected average of 3 hours

  • Arterial blood pressure

    systolic, diastolic, mean; continuous invasive measurement

    parameter will be measured continously for the duration of adrenalectomy, an expected average of 3 hours

Secondary Outcomes (4)

  • Changes in serum Concentration: Epinephrine

    7 timepoints during anesthesia (Administration of rocuronium, intubation, cut, intraabdominal air insufflation, ligature of v. suprarenalis, tumor exstirpation, end of operation)

  • Changes in serum concentration: Norepinephrine

    7 timepoints during anesthesia (Administration of rocuronium, intubation, cut, intraabdominal air insufflation, ligature of v. suprarenalis, tumor exstirpation, end of operation)

  • Changes in serum concentration: Dopamin

    7 timepoints during anesthesia (Administration of rocuronium, intubation, cut, intraabdominal air insufflation, ligature of v. suprarenalis, tumor exstirpation, end of operation)

  • Changes in plasma concentration: Metanephrines

    7 timepoints during anesthesia (Administration of rocuronium, intubation, cut, intraabdominal air insufflation, ligature of v. suprarenalis, tumor exstirpation, end of operation)

Study Arms (2)

Pheochromocytoma Group

Intraoperative esophageal doppler sonography during laparoscopic adrenalectomy performed for pheochromocytoma

Control group

Intraoperative esophageal doppler sonography during laparoscopic adrenalectomy for non-pheochromocytoma adrenal tumor

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients suffering from pheochromocytoma will be recruited by the Department of Surgery, Medical University of Vienna

You may qualify if:

  • Planned laparoscopic adrenalectomy for pheochromocytoma (Biochemical confirmed adrenal and extraadrenal pheochromocytoma)
  • Planned laparoscopic adrenalectomy for hormonally inactive adrenal tumor

You may not qualify if:

  • Risk of esophageal bleeding or perforation exists (i.e., liver disease with portal hypertension and/or esophageal varicoses, other esophageal anomalies).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Medical University of Vienna

Vienna, 1050, Austria

Location

Related Publications (1)

  • Niederle MB, Fleischmann E, Kabon B, Niederle B. The determination of real fluid requirements in laparoscopic resection of pheochromocytoma using minimally invasive hemodynamic monitoring: a prospectively designed trial. Surg Endosc. 2020 Jan;34(1):368-376. doi: 10.1007/s00464-019-06777-z. Epub 2019 Apr 11.

Biospecimen

Retention: SAMPLES WITHOUT DNA

whole blood, serum

MeSH Terms

Conditions

Pheochromocytoma

Condition Hierarchy (Ancestors)

ParagangliomaNeuroendocrine TumorsNeuroectodermal TumorsNeoplasms, Germ Cell and EmbryonalNeoplasms by Histologic TypeNeoplasmsNeoplasms, Nerve Tissue

Study Officials

  • Martin B Niederle, MD, DMedSc

    Medical University of Vienna

    PRINCIPAL INVESTIGATOR
  • Edith Fleischmann, Prof, MD

    Medical University of Vienna

    STUDY CHAIR
  • Bruno Niederle, Prof, MD

    Medical University of Vienna

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, DMedSc

Study Record Dates

First Submitted

August 24, 2011

First Posted

August 30, 2011

Study Start

August 1, 2011

Primary Completion

July 1, 2013

Study Completion

July 1, 2013

Last Updated

February 13, 2014

Record last verified: 2014-02

Locations